Aspire-Lakewood (ASBPW) Stock: Why It's Up Today
Updated Oct 23, 4:50 PM ET · latest trade in feed Oct 23, 4:00 PM ET (Finnhub)
Updated Oct 23, 3:50 PM ET · latest trade in feed Oct 23, 3:45 PM ET (Finnhub)
Updated Oct 23, 2026, 3:47 PM ET · intraday price
- Latest session (Fri Oct 23): $0.02, +$0.00 (+15.91%), volume 14.7x its 50-day average.
- Latest SEC filing: 8-K/A on Oct 20, 2026.
Sector peers moving today (Pharma & Biotech):BOLT +52.51%MGNX -36.64%TCRT -25.82%RGC -21.71%CORT -19.33%
- Trading at $0.02 as of 3:47 PM ET, +15.91% vs the prior close of $0.01.
- Volume 6.00K shares, 14.7x its 50-day average (heavy).
- New SEC filings: 8-K/A (Oct 20, 2026).
- No new insider buys or sales reported since the prior session.
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)
ASBPW jumps 15.9% to $0.02 on 14.7x normal volume. Trading at $0.02 (intraday, 3:47 PM ET), +15.91% vs the prior close of $0.01. Day range $0.02–$0.02, opened at $0.04.
Why Did ASBPW Stock Move Today?
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Last 5 sessions at a glance, then today's full note.
| Session | Close | Change | Volume vs 50-day avg | What the data shows |
|---|---|---|---|---|
| Oct 23, 2026 | $0.02 | +15.91% | — | ASBPW jumps 15.9% to $0.02 on 14.7x normal volume |
Oct 23, 2026 — ASBPW jumps 15.9% to $0.02 on 14.7x normal volume
- Trading at $0.02 (intraday, 3:47 PM ET), +15.91% vs the prior close of $0.01. Day range $0.02–$0.02, opened at $0.04.
- Volume was 6.00K shares, 14.7x its 50-day average of 409 — unusually heavy trading.
- 52-week range $0.01–$0.02; the current price sits at 100% of that range, at a new 52-week high.
Data-Driven Bull Case vs. Bear Case + Sector Peer Comparison Table
Points below restate what SEC filings and price data show. They are facts, not a recommendation.
- Share count down 97.2% in a year (buybacks).
- Latest fiscal-year net income: loss of $24.48M.
- High volatility: average daily move of 15.9% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
Sector peers · Pharmaceutical Preparations
| Ticker | Company | Last price | Day | Below 52w high | Avg $ volume (20d) |
|---|---|---|---|---|---|
| ASBPW | Aspire-Lakewood | $0.02 | +15.91% | 0.0% | $49 |
| LLY | Eli Lilly | $1,269.23 | -2.87% | 3.9% | $2.75B |
| JNJ | Johnson & Johnson | $263.86 | -1.40% | 6.1% | $2.01B |
| ABBV | AbbVie | $286.48 | +0.45% | 1.7% | $1.43B |
| MRK | Merck | $145.23 | -1.37% | 7.4% | $1.39B |
| ABT | Abbott Laboratories | $103.88 | +1.34% | 21.3% | $1.00B |
| PFE | Pfizer | $30.07 | -1.17% | 1.2% | $838.76M |
| BMY | Bristol Myers Squibb | $61.75 | -1.98% | 10.0% | $791.93M |
| VRTX | Vertex Pharmaceuticals Inc / Ma | $526.02 | -1.71% | 6.1% | $619.29M |
ASBPW Earnings Date & EPS History
Diluted EPS by fiscal quarter, from Aspire-Lakewood's 10-Q/10-K filings (SEC XBRL).
| Quarter ended | Diluted EPS |
|---|---|
| Jun 30, 2026 | $-1.22 |
| Mar 31, 2026 | $-20.57 |
| Sep 30, 2025 | $-0.04 |
| Jun 30, 2025 | $-48.19 |
| Mar 31, 2025 | $-504.88 |
| Sep 30, 2024 | $-0.01 |
ASBPW Revenue, Net Income, Cash & Debt
- Net income (quarter ended Jun 30, 2026): $-1.27M
- Cash & equivalents (as of Jun 30, 2026): $12.17M
ASBPW 52-Week High & Low
ASBPW's 52-week range is $0.01 to $0.02. At $0.02 it is 0.0% below the 52-week high and 16.8% above the 52-week low.
ASBPW Valuation: P/E, P/S, P/B, Margins & Cash vs Debt
Computed from Aspire-Lakewood's SEC XBRL filings and the latest price. A ratio is left out when its denominator is zero or negative.
| Measure | Value | How it is calculated |
|---|---|---|
| Market value | $21.46K | price $0.02 × 1.40M shares (Aug 7, 2026) |
| P/S | 3.46 | market value ÷ revenue $6.20K (FY to Dec 31, 2025) |
| P/B | 0.00 | market value ÷ shareholders' equity $11.76M (Jun 30, 2026) |
| Operating margin | -312016.9% | FY to Dec 31, 2025 |
| Net margin | -394725.1% | FY to Dec 31, 2025 |
| Cash & equivalents | $12.17M | Jun 30, 2026 |
ASBPW 5%+ Holders: Schedule 13D / 13G Filings
Filings by investors reporting a stake of 5% or more (13D = active, 13G = passive), newest first, from SEC EDGAR:
- SCHEDULE 13G/A filed Aug 14, 2026
- SCHEDULE 13G filed Aug 10, 2026
- SCHEDULE 13G/A filed Aug 6, 2026
- SCHEDULE 13G filed Jul 2, 2026
- SCHEDULE 13G filed May 15, 2026
- SCHEDULE 13G/A filed May 13, 2026
Latest ASBPW SEC 8-K & 10-Q Filings
Every SEC filing by or about ASBPW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 20, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 1.01 — Signed a material agreement.
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 4.01 — Changed its outside auditor.
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 8.01 — Reported other events the company considers important.
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 19, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $63.10K
- Net income: -$1.27M (prior year -$1.98M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$1.22 (prior year -$48.19) (loss narrowed vs Jun 30, 2025)
Aug 10, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 3.02 — Sold unregistered shares.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 6, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 2, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade ASBPW
- How much it moves: over the last 20 sessions the average daily move was 15.91% (largest 15.9%). That is a volatile stock.
- Liquidity: about 3.20K shares (≈$49) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.02 vs a range of $0.01–$0.02 (100% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 29, 2026; 8-K Sep 9, 2026; 8-K Sep 8, 2026.
- Share count: 1.40M shares outstanding (Aug 7, 2026), -97.2% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ASBPW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 0.04 | 0.02 | 0.02 | 0.02 | 6.00K |
| Oct 13, 2026 | 0.04 | 0.01 | 0.01 | 0.01 | 409 |
About Aspire-Lakewood
Aspire-Lakewood (ASBPW) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in ESTERO, FL. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1847345.
ASBPW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ASBPW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $6.20K | $-24.48M | -16.38 | $-4.92M |
| Dec 31, 2024 | — | $-1.31M | -1.90 | $-265.19K |
| Dec 31, 2023 | — | $4.46M | — | $-653.11K |
| Dec 31, 2022 | — | $3.34M | — | $-1.41M |
| Dec 31, 2021 | — | $-25.48K | — | $-238.60K |
Latest balance sheet: total assets $13.54M, total liabilities $1.78M, cash $12.17M (as of Jun 30, 2026).
ASBPW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)United Therapeutics (UTHR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Space Exploration Technologies (SPCX)Meta Platforms (META)Tesla (TSLA)Apple (AAPL)Sandisk (SNDK)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on ASBPW
Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 23, 2026, 3:47 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.